{"id":44988,"date":"2019-02-20T06:00:26","date_gmt":"2019-02-20T11:00:26","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/?p=44988"},"modified":"2019-02-19T21:17:22","modified_gmt":"2019-02-20T02:17:22","slug":"sue-siegel-to-keynote-2019-bioelectronic-medicine-forum-in-ny","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/sue-siegel-to-keynote-2019-bioelectronic-medicine-forum-in-ny\/","title":{"rendered":"Sue Siegel to Keynote 2019 Bioelectronic Medicine Forum in NY"},"content":{"rendered":"

NEW YORK, N.Y., Feb. 20, 2019 (SEND2PRESS NEWSWIRE) — Neurotech Reports<\/a>, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019. The second-annual event will be held at the Millennium Broadway Hotel & Conference Center in Times Square.<\/p>\n

\"Sue
\nSue has more than 35 years of corporate, entrepreneurial, and venture capital experience, all geared at turning untapped potential into real value. In this role, Sue leads GE Ventures, a multimodal innovation engine focused on accelerating promising start-ups, creating and launching new companies, licensing GE\u2019s intellectual property, developing new markets, and nurturing innovative ideas into scalable initiatives both inside and outside of GE.<\/p>\n

Sue is currently a board member at Align Technologies (ALGN), Illumina, Inc. (ILMN), and MIT\u2019s The Engine. She has been recognized in Fortune as one of \u201c34 Leaders Who Are Changing Health Care\u201d and as one of \u201cThe 100 Most Influential Women in Silicon Valley\u201d by Silicon Valley Business Journal.<\/p>\n

Other speakers at this year’s event include Imran Eba, partner at Action Potential Venture Capital, Evan Norton, divisional vice president at Abbott Ventures, Jeff Erb, senior director of business development at Medtronic, Kip Ludwig, associate professor at University of Wisconsin-Madison, Elliot Krames, past president of the International Neuromodulation Society, Marom Bikson, professor of biomedical engineering at City University of New York, Shai Gozani, CEO of NeuroMetrix Inc., and Victor Pikov, a former Galvani Bioelectronics scientist and now CEO of startup Medipace Inc.<\/p>\n

Several promising bioelectronic medicine entrepreneurs will be presenting at the meeting. These include Daniel Powell, CEO of Spark Biomedical, Thomas Oxley, CEO of Synchron Inc., developer of the Stentrode device, Jennifer Ernst, CEO of Tivic Health, Don Deyo, CEO of FemPulse LLC, Doug Adams, CEO of Qura Inc., Nader Yaghoubi, CEO of PathMaker Neurosystems Inc., and Samuel Hamner, director of technology and product marketing at Cala Health. Also presenting will be Gaurev Sharma from Battelle and Jake Zabara from the Jacob Zabara Family Foundation. Dr. Zabara was the original developer of vagus nerve stimulation for epilepsy and a cofounder of Cyberonics Inc. (now LivaNova).<\/p>\n

Key topics will include promising indications, alliances with bio\/pharm firms, regulatory and reimbursement issues, and pricing\/commercialization issues.<\/p>\n

\u201cBioelectronic medicine is one of the most promising new segments of the healthcare industry,\u201d said James Cavuoto, editor and publisher at Neurotech Reports. \u201cThis second-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry.\u201d<\/p>\n

For more information on the 2019 Bioelectronic Medicine Forum, contact Neurotech Reports at (415) 546 1259 or visit this link: http:\/\/neurotechreports.com\/pages\/bioelectronic-medicine-forum.html<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, N.Y., Feb. 20, 2019 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019.<\/p>\n","protected":false},"author":3345,"featured_media":44987,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[602,1,243,61,8,603,5,293],"tags":[10845,10847,10846],"class_list":["post-44988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology-news","category-business-news","category-electronics-news","category-health-medical-news","category-new-york-news","category-neurotech-news","category-technology-news","category-trade-show-news","tag-bioelectronic-medicine-forum","tag-chief-innovation-officer","tag-ge-ventures","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":7162,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/44988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/3345"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=44988"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/44988\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/44987"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=44988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=44988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=44988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}